A carregar...
Cholinesterase inhibitors may not benefit mild cognitive impairment and mild Alzheimer disease dementia
INTRODUCTION: We investigated whether cholinesterase inhibitors (ChEIs) benefit cognitive outcomes in mild cognitive impairment (MCI) due to Alzheimer disease (AD) and in mild AD dementia. METHODS: Data from 2,242 individuals, clinically diagnosed with MCI due to AD (MCI-AD, Clinical Dementia Rating...
Na minha lista:
| Publicado no: | Alzheimer Dis Assoc Disord |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6542289/ https://ncbi.nlm.nih.gov/pubmed/30633043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WAD.0000000000000291 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|